Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2231703 | 0.97 | TSHR (0.33) | TSHR | |
| SCHEMBL4731263 | 0.97 | TSHR (0.33) | TSHR | |
| Glycerin SCHEMBL3242944 | 0.87 | LMNA (0.38) | TSHR | |
| SCHEMBL11348448 | 0.85 | — | — | |
| SCHEMBL933651 | 0.82 | — | — | |
| SCHEMBL9290679 | 0.81 | — | — | |
| SCHEMBL37544 | 0.79 | HDAC1 (0.39) | TSHRRECQL | |
| SCHEMBL9246019 | 0.79 | — | — | |
| SCHEMBL6384916 | 0.79 | CA2 (0.30) | — | |
| Hydrochloric Acid SCHEMBL5066545 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 412 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025235121-A1 | TIRAPAZAMINE COMPOSITIONS AND METHODS | Teclison, Inc. (US) | 2025-11-13 | — | — | WO | claimed |
| US-20250345356-A1 | TIRAPAZAMINE COMPOSITIONS AND METHODS | Teclison, Inc. (US) | 2025-11-13 | — | — | US | claimed |
| CN-115317439-A | Keliboro microneedle patch and preparation method thereof | 合肥博思科创医药科技有限公司 | 2022-11-11 | — | — | CN | claimed |
| US-20210212321-A1 | STABILIZED FUNGICIDAL COMPOSITION COMPRISING CYCLODEXTRIN | BAYER CROPSCIENCE LP | 2021-07-15 | — | — | US | claimed |
| EP-2152078-B1 | FORMULATIONS CONTAINING CLOPIDOGREL AND SULFOALKYL ETHER CYCLODEXTRIN AND METHODS OF USE | CYDEX PHARMACEUTICALS INC (US) | 2021-01-13 | — | — | EP | claimed |
| CN-104800210-B | Preparation comprising clopidogrel and sulfoalkyl ether cyclodextrin and its application method | 锡德克斯药物公司 | 2019-08-06 | — | — | CN | claimed |
| EP-1732512-B1 | INHALANT FORMULATION CONTAINING SULFOALKYL ETHER CYCLODEXTRIN AND CORTICOSTEROID | CYDEX PHARMACEUTICALS INC (US) | 2017-03-22 | — | — | EP | claimed |
| EP-1594434-B1 | PARENTERAL FORMULATIONS OF PEPTIDES FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS | YEDA RES & DEV (IL) | 2016-09-07 | — | — | EP | claimed |
| US-20160010086-A1 | OLIGOMERIC COMPOUNDS AND EXCIPIENTS | ISIS PHARMACEUTICALS, INC. (US) | 2016-01-14 | — | — | US | claimed |
| CN-104800210-A | Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use | CYDEX PHARMACEUTICALS INC | 2015-07-29 | — | — | CN | claimed |
| EP-1409592-B1 | WATER-BASED COLORANT PREPARATIONS | CLARIANT GMBH (DE) | 2005-09-14 | — | — | EP | claimed |
| US-20050008634-A1 | Parenteral formulations of peptides for the treatment of systemic lupus erythematosus | TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) | 2005-01-13 | — | — | US | claimed |
| US-6811673-B2 | ZINC, OR ALLOY THEREOF, MATTE FINISHING; AUTOMOBILE PROTECTIVE COATING | BASF AKTIENGESELLSCHAFT (DE) | 2004-11-02 | — | — | US | claimed |
| US-20040206271-A1 | Water-based colorant preparations | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2004-10-21 | — | — | US | claimed |
| US-20040180059-A1 | Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus | YEDA RESEARCH AND DEVELOPMENT CO. (IL) | 2004-09-16 | — | — | US | claimed |
| WO-2004064788-A2 | PARENTERAL FORMULATIONS OF A PEPTIDE FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS | TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) | 2004-08-05 | — | — | WO | claimed |
| WO-2004064787-A2 | PARENTERAL FORMULATIONS OF PEPTIDES FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS | TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) | 2004-08-05 | — | — | WO | claimed |
| EP-1409592-A1 | WATER-BASED COLORANT PREPARATIONS | Clariant GmbH (DE) | 2004-04-21 | — | — | EP | claimed |
| WO-2003008503-A1 | WATER-BASED COLORANT PREPARATIONS | CLARIANT GMBH (DE) | 2003-01-30 | — | — | WO | claimed |
| US-20010034333-A1 | Cyclodextrin polymer compositions for use as drug carriers | KOSAK KENNETH M (US) | 2001-10-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010034333-A1 | Cyclodextrin polymer compositions for use as drug carriers | ABCB1, ABCG2, CTTN | TSHR 4603/4885RECQL 1905/4885 |
| US-20210212321-A1 | STABILIZED FUNGICIDAL COMPOSITION COMPRISING CYCLODEXTRIN | CYP3A43, POR, CBR3 | TSHR 4025/4885RECQL 2331/4885 |
| US-20160010086-A1 | OLIGOMERIC COMPOUNDS AND EXCIPIENTS | HNRNPA3, SNRPE, HNRNPA1 | TSHR 4274/4885RECQL 722/4885 |
| US-20250345356-A1 | TIRAPAZAMINE COMPOSITIONS AND METHODS | TYMP, ROR1, CSNK1A1 | TSHR 1442/4885RECQL 248/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.